問卷

TPIDB > Principal Investigator

Principal Investigator


Linkou Chang Gung Medical Foundation (在職)

Division of Orthopedics

更新時間:2023-09-19

陳品元Chen, Pin-Yuan
  • Principal Investigator
  • Clinical Trial Experience (year) 17 years 9 個月
  • pinyuanc@gmail.com

Publication

30Publications

21

Prediction of Malignant Transformation of WHO II Astrocytoma Using Mathematical Models Incorporating Apparent Diffusion Coefficient and Contrast Enhancement.

22

Prevalence of sleep disturbances and their effects on quality of life in adults with untreated pituitary tumor and meningioma.

23

Prevalence of sleep disturbances and their effects on quality of life in adults with untreated pituitary tumor and meningioma.

24

Prevalence of sleep disturbances and their effects on quality of life in adults with untreated pituitary tumor and meningioma.

25

Receptor-Interacting Protein 140 Enhanced Temozolomide-Induced Cellular Apoptosis Through Regulation of E2F1 in Human Glioma Cell Lines.

26

Reprogramming of arachidonate metabolism confers temozolomide resistance to glioblastoma through enhancing mitochondrial activity in fatty acid oxidation.

27

Roles of Neutrophils in Glioma and Brain Metastases.

28

The Effect of Acupressure on Relieving Cancer-Related Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

29

The Merits of Awake Craniotomy for Glioblastoma in the Left Hemispheric Eloquent Area: One Institution Experience.

30

Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53-PUMA Apoptosis Pathway.
1 2 3